Results

Total Results: 455 records

Showing results for "malignant neoplasm".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-anemia-update_research-protocol.pdf
    June 16, 2010 - The prevalence of anemia varies according to the type of neoplasia.7 Patients with hematological malignancies … versus hematological malignancies versus mixed (studies including both solid tumors and hematological … * OR tumor OR tumors OR tumour* OR neoplas* OR carcinom* #59 Search erythropoietin OR epoetin* OR … "[Mesh] OR "Carcinoma"[Mesh] OR malignan* OR cancer OR cancers OR cancerous OR oncolog* OR myelodysplas … * OR tumor OR tumors OR tumour* OR neoplas* OR carcinom*) AND ("adverse effects "[Subheading
  2. hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2012_MaskedStats_Severity_V2.PDF
    January 01, 2012 - electrolyte disorders 13,459,216 0 0.00 1.00 0.21 0.41 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 13,459,216 0 0.00 1.00 0.11 0.31 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 11,811 0.09% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 7,576 0.06% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 9,897 0.07% 690 … 18,144 0.13% 692: Radiotherapy 1,115 0.01% 693: Chemotherapy 58,907 0.44% 694: Lymphatic & other malignancies
  3. hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2013_MaskedStats_Severity.PDF
    January 01, 2013 - electrolyte disorders 14,325,172 0 0.00 1.00 0.22 0.42 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 14,325,172 0 0.00 1.00 0.11 0.32 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 11,987 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … Percent of Total 692: Radiotherapy 1,114 0.01% 693: Chemotherapy 62,706 0.44% 694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 12,072 0.08% 710: Infectious & parasitic diseases including HIV w
  4. hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2011_MaskedStats_V2_Severity.PDF
    January 01, 2011 - electrolyte disorders 13,915,176 0 0.00 1.00 0.21 0.40 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 13,915,176 0 0.00 1.00 0.10 0.31 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 12,699 0.09% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 18,617 0.13% 692: Radiotherapy 1,207 0.01% 693: Chemotherapy 61,609 0.44% 694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 12,416 0.09% 710: Infectious & parasitic diseases including HIV w
  5. hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2010_MaskedStats_Severity_V2.PDF
    January 01, 2010 - electrolyte disorders 13,907,610 0 0.00 1.00 0.20 0.40 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 13,907,610 0 0.00 1.00 0.10 0.30 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 12,922 0.09% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 18,995 0.14% 692: Radiotherapy 1,534 0.01% 693: Chemotherapy 61,552 0.44% 694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 12,680 0.09% 710: Infectious & parasitic diseases including HIV w
  6. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2011_MaskedStats_Severity.PDF
    January 01, 2011 - electrolyte disorders 8,023,590 0 0.00 1.00 0.20 0.40 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 8,023,590 0 0.00 1.00 0.10 0.30 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 6,517 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,946 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 5,098 0.06% 690 … & neoplasms of uncertain behavior 6,509 0.08% 710: Infectious & parasitic diseases including HIV w
  7. hcup-us.ahrq.gov/datainnovations/clinicaldata/File1_AHCA_Presentation_To_AHSS_On_POA.jsp
    August 01, 2011 - Final dx malignant neoplasm with metastasis.
  8. hcup-us.ahrq.gov/db/nation/nis/APS-DRGsV20DefinitionsManual.pdf
    January 13, 2015 - PROCS 172 172 DIGESTIVE MALIGNANCY 173 172 DIGESTIVE MALIGNANCY 174 174 G.I. … PROC 202 205 DISORDERS OF LIVER, EX MALIGNANCY 203 203 MALIGNANCY OF HEPATOBIL SYST OR PANCREAS … 204 204 DISORDERS OF PANCREAS EXCEPT MALIGNANCY 205 205 DISORDERS OF LIVER, EX MALIGNANCY 206 205 … 258 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY 259 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY 260 CDRG … PROC 366 366 MALIGNANCY, FEMALE REPRO SYSTEM 367 366 MALIGNANCY, FEMALE REPRO SYSTEM 368 368
  9. hcup-us.ahrq.gov/db/nation/nis/APS-DRGs%20V21%20Definitions%20Manual.pdf
    January 13, 2015 - PROCS 172 172 DIGESTIVE MALIGNANCY 173 172 DIGESTIVE MALIGNANCY 174 174 G.I. … PROC 202 205 DISORDERS OF LIVER, EX MALIGNANCY 203 203 MALIGNANCY OF HEPATOBIL SYST OR PANCREAS … 204 204 DISORDERS OF PANCREAS EXCEPT MALIGNANCY 205 205 DISORDERS OF LIVER, EX MALIGNANCY 206 205 … 258 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY 259 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY 260 CDRG … PROC 366 366 MALIGNANCY, FEMALE REPRO SYSTEM 367 366 MALIGNANCY, FEMALE REPRO SYSTEM 368 368
  10. hcup-us.ahrq.gov/reports/statbriefs/sb30.pdf
    May 01, 2007 - TURP—a procedure involving no incision—is most commonly used to treat benign tumors of the prostate, … secondary malignancies, or metastatic cancer. … The following ICD-9-CM diagnosis codes are included in CCS category 29, Prostate Cancer: – 185 Malignantneoplasm of prostate – 233.4 Carcinoma in situ of prostate – V10.46 Personal history of malignantneoplasm—prostate Procedures and Clinical Classifications Software (CCS) The principal procedure
  11. hcup-us.ahrq.gov/reports/statbriefs/sb270-Cancer-Hospitalizations-Adults-2017.pdf
    January 01, 2017 - ■ The most common principal cancer diagnoses in 2017 were secondary malignancies, colorectal cancer … 394.3 Malignant neuroendocrine tumors 13,800 6.9 22,100 3,200 305.0 Head and neck cancers - lip and … The most common adult hospitalizations principally for cancer in 2017 were for secondary malignancies … Aggregate costs were highest for the same set of cancers: secondary malignancies ($3.5 billion), colorectal … of cancer 1,732,900 100.0 Secondary malignancies 569,800 32.9 Respiratory cancers 248,800 14.4 Non-Hodgkin
  12. hcup-us.ahrq.gov/reports/natstats/commdx/table1h.htm
    February 11, 2011 - Cancer of head and neck [11] 4,951 7.17 0.01 … Other and unspecified benign neoplasm [47] 8,188 12.57 0.02 … Secondary malignancies [42] 3,784 5.91 0.01 … Other and unspecified benign neoplasm [47] 8,058 12.64 0.02 … Neoplasms of unspecified nature 2,911 4.65 0.01
  13. hcup-us.ahrq.gov/reports/natstats/his96/table1.pdf
    February 11, 2011 - Benign neoplasm of uterus [46.] 222,765 0.64 $8,551 $5,702 $7,746 $10,317 3.0 0.0 … 0.0 43.8 2.16.2 Other and unspecified benign neoplasm 151,779 0.44 $13,848 $5,700 … 2.16.2.2 Benign neoplasm of colon 26,537 0.08 $13,071 $5,756 $9,785 $15,546 5.9 … 0.7 48.5 69.4 2.16.2.3 Benign neoplasm of the thyroid 12,419 0.04 $6,806 $4,265 $5,936 … $8,074 1.7 0.0 18.6 49.3 2.16.2.4 Benign neoplasm of cerebral meninges 12,413 0.04
  14. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1998_SummaryStats.PDF
    January 01, 1998 - cancer of skin 1307 0.02 24: Cancer of breast 23825 0.35 25: Cancer of uterus 7081 0.10 26: Cancer … 29: Cancer of prostate 17389 0.25 30: Cancer of testis 383 0.01 31: Cancer of other male genital … , other Unspecified primary 2048 0.03 42: Secondary malignancies 52242 0.77 43: Malignant neoplasm … 0.12 45: Maintenance chemotherapy, radiotherapy 37316 0.55 46: Benign neoplasm of uterus 44178 0.65 … 47: Other unspecified benign neoplasm 29162 0.43 48: Thyroid disorders 7118 0.10 49: Diabetes mellitus
  15. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1999_SummaryStats_CORE10B.PDF
    January 01, 1999 - cancer of skin 128 0.02 24: Cancer of breast 2507 0.35 25: Cancer of uterus 815 0.11 26: Cancer of … : Cancer of prostate 2126 0.30 30: Cancer of testis 40 0.01 31: Cancer of other male genital organs … , other Unspecified primary 192 0.03 42: Secondary malignancies 5080 0.71 43: Malignant neoplasm without … 45: Maintenance chemotherapy, radiotherapy 3650 0.51 46: Benign neoplasm of uterus 4972 0.69 47: Other … unspecified benign neoplasm 3463 0.48 48: Thyroid disorders 742 0.10 49: Diabetes mellitus without
  16. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1998_SummaryStats_CORE10B.PDF
    January 01, 1998 - cancer of skin 149 0.02 24: Cancer of breast 2373 0.35 25: Cancer of uterus 692 0.10 26: Cancer of … : Cancer of prostate 1786 0.26 30: Cancer of testis 31 0.00 31: Cancer of other male genital organs … , other Unspecified primary 246 0.04 42: Secondary malignancies 5283 0.77 43: Malignant neoplasm without … 45: Maintenance chemotherapy, radiotherapy 3740 0.55 46: Benign neoplasm of uterus 4354 0.64 47: Other … unspecified benign neoplasm 2870 0.42 48: Thyroid disorders 681 0.10 49: Diabetes mellitus without
  17. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1999_SummaryStats.PDF
    January 01, 1999 - cancer of skin 1315 0.02 24: Cancer of breast 24405 0.34 25: Cancer of uterus 7566 0.11 26: Cancer … 29: Cancer of prostate 20728 0.29 30: Cancer of testis 393 0.01 31: Cancer of other male genital … , other Unspecified primary 1858 0.03 42: Secondary malignancies 50461 0.70 43: Malignant neoplasm … 0.12 45: Maintenance chemotherapy, radiotherapy 36883 0.51 46: Benign neoplasm of uterus 48732 0.68 … 47: Other unspecified benign neoplasm 34867 0.48 48: Thyroid disorders 7555 0.10 49: Diabetes mellitus
  18. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1999_SummaryStats_CORE10A.pdf
    January 01, 1999 - cancer of skin 150 0.02 24: Cancer of breast 2403 0.33 25: Cancer of uterus 755 0.10 26: Cancer of … : Cancer of prostate 2035 0.28 30: Cancer of testis 45 0.01 31: Cancer of other male genital organs … , other Unspecified primary 193 0.03 42: Secondary malignancies 5023 0.70 43: Malignant neoplasm without … 45: Maintenance chemotherapy, radiotherapy 3634 0.50 46: Benign neoplasm of uterus 4924 0.68 47: Other … unspecified benign neoplasm 3469 0.48 48: Thyroid disorders 773 0.11 49: Diabetes mellitus without
  19. hcup-us.ahrq.gov/reports/methods/2006_1.pdf
    January 01, 2006 - For example, if a patient presents with a lump and it is diagnosed as a malignant neoplasm during the … hospitalization, the malignant neoplasm should be considered to be present on admission. … For example, “personal history of malignant neoplasm” cannot develop after admission. … Neoplasm Bronchus or Lung 11,303 11,244 99.48 1,311 1,302 99.3% 174.9 Malignant Neoplasm Breast 4,735 … 4,724 99.77 960 952 99.2% 185 Malignant Neoplasm Prostate 14,486 14,438 99.67 4,855 4,781 98.5% 250.00
  20. hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2015Q1Q3_Severity.PDF
    November 08, 2017 - electrolyte disorders 5,377,720 0 0.00 1.00 0.22 0.42 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 5,377,720 0 0.00 1.00 0.11 0.32 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 3,979 0.07% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 2,580 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 3,152 0.06% 690 … & neoplasms of uncertain behavior 3,745 0.07% 710: Infectious & parasitic diseases including HIV w

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive